Several synthetic opioids are significantly stronger than fentanyl. Carfentanil, the most well-known, is 100 times more potent. A newer class called nitazenes can be up to 20 times stronger. Even within the medical fentanyl family, there are close relatives with considerably more punch.
Carfentanil: 100 Times Fentanyl’s Potency
Carfentanil is the most potent opioid that has been manufactured at any meaningful scale. It is 10,000 times more potent than morphine and 100 times more potent than fentanyl. To put that in perspective, fentanyl itself is already 100 times stronger than morphine and 50 times stronger than heroin. A 2-milligram dose of fentanyl, roughly the size of a few grains of salt, is considered potentially lethal for most people. Carfentanil operates at a fraction of that amount.
Carfentanil’s only approved use is as a tranquilizer for large animals. Veterinarians use it to immobilize elephants and other megafauna. It has no approved human medical application. Despite that, it has appeared in the illicit drug supply, often mixed into heroin or counterfeit pills, and has been linked to mass overdose events in several U.S. states and in Canada.
Nitazenes: The Rising Threat
Nitazenes are a class of synthetic opioids, sometimes called benzimidazoles, that were originally developed in the 1950s but never approved for medical use. They have resurfaced in the illicit drug market and now represent one of the most dangerous trends in overdose deaths. As a class, nitazenes are estimated to be 1.5 to 20 times more potent than fentanyl, depending on the specific compound.
One of the more common nitazenes appearing in seized drugs is metonitazene. In 2023, U.S. authorities intercepted tablets from international mail shipments destined for Florida, Connecticut, and Brazil. Each tablet contained an average of 29 milligrams of metonitazene, equivalent to roughly 290 milligrams of fentanyl in a single pill. The DEA estimates that 2 milligrams of fentanyl can be fatal, making each of those tablets approximately 145 times the lethal dose. Another batch of metonitazene-only tablets averaged 35 milligrams per pill, equivalent to about 350 milligrams of fentanyl.
Other nitazene variants include isotonitazene and protonitazene, both of which have been identified in overdose deaths across the U.S. and Europe. These compounds are especially dangerous because they often appear in pills or powders sold as something else entirely, and users have no way of knowing what they’ve taken.
How Overdose Reversal Gets Harder
Naloxone, the medication used to reverse opioid overdoses, still works against these ultra-potent drugs. That’s the good news. The complication is that more potent opioids often require multiple doses of naloxone, and they may take longer to reverse. The CDC has confirmed that naloxone is effective against nitazene-involved overdoses but notes that multiple doses might be needed.
Part of the challenge is pharmacological. Many of these stronger synthetics are highly fat-soluble and bind very tightly to opioid receptors in the brain. They dissociate slowly, meaning a single dose of naloxone may wear off before the drug does, causing the person to slip back into respiratory failure. This is why someone revived from a suspected overdose involving these substances needs ongoing monitoring, not just a single rescue dose.
Stronger Opioids Used in Human Medicine
Not every opioid stronger than fentanyl is illicit. Sufentanil is a close chemical relative of fentanyl that is used in hospitals and surgical settings. The FDA reports it is 5 to 7 times as potent as fentanyl when used as a primary anesthetic, and up to 10 times as potent in certain balanced anesthesia protocols. It is used during major surgeries and in epidural pain management during labor. Because it is administered in tightly controlled clinical settings with precise dosing equipment, its extreme potency is managed safely.
Opioids Used Only in Veterinary Settings
Etorphine, sometimes known by its trade designation M99, is roughly 2,000 times more potent than morphine, placing it at about 20 times fentanyl’s strength. It is used exclusively to immobilize large wild animals for veterinary procedures, tagging, or relocation. Interestingly, many non-human mammals do not experience the same degree of respiratory depression that makes these drugs so lethal to people, which is why etorphine works well as an animal tranquilizer but has no human application.
Lofentanil, another fentanyl analog studied in laboratory settings, has been measured at roughly 4,500 times the potency of morphine in animal pain models, making it approximately 45 times stronger than fentanyl. It has never been approved for any clinical use.
Compounds That Aren’t What They Seem
One substance that generated significant media attention is W-18, which was widely reported as being “10,000 times stronger than morphine” after it was found in drug seizures in Canada. Comprehensive pharmacological testing at Washington University has since shown that W-18 has no detectable activity at any of the four types of opioid receptors. It also showed no painkilling effect in standard animal tests, and its metabolites are equally inactive at opioid receptors. Whatever W-18 does, it does not appear to function as an opioid at all, despite years of alarming headlines. Its actual pharmacological profile remains poorly understood, but calling it a super-potent opioid is not supported by the evidence.
Why Potency Comparisons Matter
When a drug is more potent than fentanyl, it doesn’t necessarily produce a “stronger high.” Potency refers to how little of the substance is needed to produce an effect. A drug that is 100 times more potent than fentanyl achieves the same biological result at one-hundredth the dose. This is what makes these substances so dangerous in the real world: the margin between an active dose and a lethal dose becomes vanishingly small, often invisible to the naked eye.
For illicit drug manufacturers, higher potency also means easier smuggling. Smaller quantities can be shipped, then cut and distributed across thousands of doses. This economic logic is a key reason why the drug supply has shifted toward ever-more-potent synthetics over the past decade, moving from heroin to fentanyl and now, increasingly, to nitazenes and other ultra-potent compounds.